September 4th, 2007
Experimental Cancer Drug Cyclopamine Kills Brain Tumor Stem Cells
The experimental compound cyclopamine was previously known to shut down a critical cell-signaling pathway (Hedgehog) in the most common and aggressive type of adult brain cancer: glioblastoma multiforme.
Now, according to Johns Hopkins scientists, cyclopamine have been able to successfully kill cancer stem cells thought to fuel tumor growth and help cancers evade drug and radiation […]
Recent Comments